Back to Search
Start Over
A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.
- Source :
- Clinical Lung Cancer; 2012 Jan, Vol. 13 Issue 1, p31-38, 8p
- Publication Year :
- 2012
Details
- Language :
- English
- ISSN :
- 15257304
- Volume :
- 13
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Clinical Lung Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 108220232
- Full Text :
- https://doi.org/10.1016/j.cllc.2011.06.010